Prerpints.org logo
Preprint
Review

Nailfold Capillaroscopy: A Comprehensive Review on Its Usefulness Not Only in Clinical Diagnosis, but Also in Unhealthy Dietary Lifestyle Improvements

Altmetrics

Downloads

237

Views

97

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

01 April 2024

Posted:

02 April 2024

You are already at the latest version

Alerts
Abstract
Since the 1970s, the usefulness of nailfold capillaroscopy (NFC) in the diagnosis of rheumatological disorders such as systemic sclerosis has been well known, and further studies also showed that NFC can detect non-rheumatic diseases such as diabetes, glaucoma, dermatitis, Alzheimer disease, and so on. In the past decade, the morphological changes in the nailfold capillary have been also reported in the unhealthy lifestyle habits such as smoking, inappropriate diets, sleep shortage, and even psychological stress which presents slow blood flow. Therefore, study in the relationships between the morphology of nailfold capillaries and lifestyle habits has high potential to understand the unhealthy state, or even predict the pre-disease condition. So, simple, inexpensive, and non-invasive methods such as NFC are constantly needed for routine health checkups. Thus, we undertook a systematic search in PubMed database, and summarized the studies reporting the assessment of morphological NFC in order to undertake a comprehensive review on the usefulness of NFC not only in clinical diagnosis, but also in unhealthy dietary lifestyle improvements. Here in this review paper, we finally summarized the dietary and lifestyle health promotion strategy judging from NFC- and the other relating-measurement from the viewpoint of healthy microvascular blood flow and endothelial function.
Keywords: 
Subject: Biology and Life Sciences  -   Life Sciences

1. Introduction

Nailfold capillaroscopy (NFC) is a simple, non-invasive, highly sensitive, safe, reliable, and inexpensive tool, that is designed to assess multiple features of the nailfold capillaries, including blood flow, density, and different kinds of abnormal morphology. It can provide visual inspection for microcirculation in our body. Since the 1970s, NFC has gained recognition in the field of diseases that affect microcirculation, especially in many rheumatological disorders, such as connective tissue diseases (CTD); i.e., rheumatic diseases like systemic sclerosis (SSc), systemic lupus erythematosus (SLE), inflammatory myositis, rheumatoid arthritis (RA), and so on. Poor lifestyle and dietary habits can also cause cardiovascular diseases, cancer, diabetes, and Alzheimer's disease, and other lifestyle-related diseases. Healthy life style, including moderate exercise and reducing psychological stress, smoking, and alcoholic intake, can prevent diseases. As a matter of fact, full articles published from 1980 to 2023 retrieved from PubMed using the search word “nailfold capillaroscopy” are represented in Figure 1 that is paralleled well with previous paper [1].
The 2013 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for SSc counts 2 out of the minimum 9 points needed for the pathology classification for NFC SSc-specific findings ([2], 2013). The inclusion of the capillaroscopic evaluation in the SSc classification criteria was based on its role in early SSc diagnosis; later the capillaroscopy indications expanded ([3,4,5,6]. Moreover, standardization guidelines for capillaroscopy practice for Raynaud’s phenomenon (RP) and SSc were published by the EULAR study group on microcirculation in rheumatic diseases and the scleroderma clinical trials consortium group on capillaroscopy recently ([1], 2020).
NFC's usefulness in the diagnosis of SSc is well known, and in other rheumatic conditions such as other connective tissue diseases, e.g., vasculitis, and arthritis, the nailfold video-capillaroscopy (NVC) anomalies are often included in a scleroderma like pattern. The utility of NFC in non-rheumatic disease (NRD) has not been well studied, therefore recent Italian extensive research [7] was performed using PUBMED and GOOGLE SCHOLAR databases to identify studies using published papers relating non-rheumatic diseases between 1990 and 2019. Various diseases, such as diabetes, glaucoma, dermatology, sickle cell disease (SCD), interstitial lung disease (ILD), idiopathic pulmonary hypertension (i-PAH), Alzheimer disease (AD), Rett syndrome (RS) cause microvascular damage, that can be detected by capillaroscopy. NFC allows to evaluate the measurements of individual capillaries (length, shape, and diameter of each capillary loop, the number of capillaries), hemorrhage, avascular area, angiogenesis, and the dynamic parameters (blood flow velocity, using a software program) [8]. Actually, studies published in the last decades have demonstrated the importance of this innovative technique in these diseases (diabetes mellitus, glaucoma, essential hypertension, psoriasis (dermatology), cardiovascular disease, chronic kidney disease (CKD), Alzheimer's disease) [9]. For example, one of the systematically reviewed papers concluded that NFC findings such as reduced capillary density and length, dilated capillaries, micro-hemorrhages, tortuosity, ectasic loops, avascular areas or ramified capillaries, aneurysms are not infrequent, even in patients with no underlying CTD. A summary of the included studies with all significant differences in capillaroscopic findings between patients and controls is provided in that paper [9] and above-mentioned Dima’s paper ([3]). Recent studies conclude that capillaroscopy provides key data for the determination of vascular damage in diabetic patients and thus, allows the evaluation of the progression of the disease [9], making this technique a potential future utility in the microvascular disease evaluation. Maldonado et al. demonstrated that the use of capillaroscopy in patients with diabetes allows the identification of capillaroscopic abnormalities, possibly including a characteristic pattern in this group of patients consisting of tortuous, cross-linked capillaries, avascular zones and ectasias, also the study showed an association between microangiopathies seen at the ophthalmoscopy and the presence of ramified capillaries and avascular zones seen at the nailfold level [10,11].
In addition to this NFC measurement, we expanded the dietary habit survey into microcirculation measurement by other methods because there have been few papers published concerning the NFC and dietary habits. Therefore, we finally summarized the dietary and lifestyle recommendation for peripheral artery disease (PAD) prevention from the viewpoint of microvascular blood flow.

2. Normal Capillaroscopy Pattern in Healthy Subjects

We undertook a systematic search in PubMed database and scientific website surveys, and selected the studies reporting quantitative and/or qualitative assessment of morphological NFC in order to undertake a comprehensive review on the usefulness of NFC not only in clinical diagnosis, but also in unhealthy dietary lifestyle improvements. We concentrated the latter case category because there have been few published papers in the healthy subject category up to now. Even though we selected not only “randomized controlled trial studies” but also other pilot studies, our search strategy identified 243 original and 84 review articles from 1999 to 2023, and only 8 and no articles were retrieved from the viewpoint of dietary habitual lifestyle in the original and review paper category respectively. Therefore, we focused on 8 original papers basically in the present paper to generalize the NFC application for the life-style improvement. Surveyed results of recently published NFC papers in the present study are shown in Figure 2.
Dima, A, et al. totally summarized the qualitative NFC assessment in healthy subjects as follows that shows homogeneous capillaries distribution in the field examined. Most frequently, the capillaries are stand perpendicularly to the nail edge [12,13]. The terminal row of capillaries is arranged in parallel fashion and grant a full-length description of the capillary [13] with U-shaped [14]. Under the rows of capillaries, the subpapillary venous plexus might be seen and appears of greater diameter [15]. The arterial afferent loop is thinner than the venous efferent one [12]. Besides the hairpin shape, other two discrete abnormalities, nonspecific variations are recognized for the normal pattern: tortuous (the loops undulate but do not cross) and crossing (loops crossed once or twice) capillaries that together with the hairpin shape are considered normal [1]. Besides these three shapes (hairpin, tortuous, crossing) all the other are defined as abnormal morphologies [1]. Ingegnoli, F., et al. described the morphological aspects of the capillaries as hairpin shaped loop, loops with one cross, loops with more than two intersections, as well as meandering loops and proposed three main capillaroscopic patterns for normal variations found in healthy subjects, namely first one “normal” with 2–5 U-shaped loops/mm and maximum 2 tortuous loops/mm; the second one, named also “perfect normal” which consists of more or equal than 5 U-shaped loops–/mm, and the third one, “unusual normal” consisting in at least any of the following: one meandering, one bushy loop, one microhemorrhage, or more than 4 crossed loops/mm [16]. Therefore, unusual capillaries like intercrossed, tortuous, elongated, or disorganization of the capillaries might occur even in subjects without underlying SSD (scleroderma spectrum disorders) [15]. Counting the number of capillaries reported to distance (per mm) is important for defining normality [16]. Different authors defined various limits for the normal capillary density; like 9–14 (average 10) capillaries/ mm [5], 7–10 capillaries/ mm [16], 9–13 capillaries/ mm [17], 6–14 capillaries/mm [15], 7–12 capillaries [18]. A recent standardization of the EULAR study group for microcirculation in rheumatic diseases stated that more than 7 capillaries/ mm define normal density [1] (see Table 1). Similarly, the reports for capillaries loops diameter or length are not uniform. The ectasia was initially defined as having 4–9 times higher, while the giant capillaries more than 10 times higher than normal diameter [12]. Further, the normal diameter of the afferent branch of 6–19 µm and 8–20 µm for the efferent branch, with diameters of more than 50 µm defining the mega/ giant capillaries, [12,15,17]. By consensus, it was recently established that a diameter of maximum 20 µm for normal diameter and 50 µm for ectasia [1]. The loop length is representing the visible part of the capillaries and normal ranges were reported by some authors of 200–250 µm [15], but also up to 500 µm [16,17], while elongated capillaries have length of more than 300 µm, 500 µm or even 700 µm [19]. Microhemorrhages might be seen in healthy individuals in case of local trauma in which its position is closer to the nail and not related to a giant capillary recently collapsed [12]. Overall characteristics of nailfold capillaroscopic morphology in healthy subjects were summarized in Table 2 [13,14,16,17].
After Dima, A., et al. [3]; Kayser, C., et al. [12]; Chojnowski, M.M., et al. [6]; Cutolo, M. [4]; and Smith, V., et al [1].

3. Nailfold Capillary Patterns Correlate with Age, Gender, Lifestyle Habits

Poor lifestyle and dietary habits can cause cardiovascular diseases [20], cancer [21], diabetes [20], and Alzheimer's disease [23], and other lifestyle-related diseases. Healthy lifestyle, including moderate exercise and reducing psychological stress, smoking, and alcoholic intake, can prevent diseases. For routine health checkups, simple, inexpensive, and non-invasive methods are constantly needed. Actually, the morphological changes in the nailfold capillary have been reported in the unhealthy lifestyle habits such as smoking [24], sleep shortage, and even psychological stress presents slow blood flow [25]. Therefore, study in the relationships between the morphology of nailfold capillaries and lifestyle habits has high potential to understand the unhealthy state, or even predict the pre-disease condition [26,27]. Therefore, several papers described that the normality or normal range of the nailfold capillaries has been investigated in healthy individu- als in terms of nailfold capillary morphology [16,26,27,28,29]. Here, we selected 4 papers relating to dietary habits, out of 8 “non-patient” papers.
< Example 1: Nailfold capillaroscopy (NFC) of healthy individuals: --- An observational study [26] >
The morphology and capillary density in the nailfold capillaries of healthy individuals were studied and analyzed. The study concludes that various capillary morphology findings such as tortuosity, dilated, meandering, bushy capillaries, and decreased plexus visibility can be present in non-clinical individuals with BMI greater than 25 that was statistically significant (p-value 0.0222, in "Plexus" capillary visibility); and "Tortuous" capillary (p-value of 0.0002) and “Receding” capillary (p-value 0.0229) were more frequently seen in the aged group greater than 41 years (Table 3). They have also suggested that those appearance in more than two fingers should be considered for it to be pathological.
< Example 2: Application of NFC for the lifestyle management [27] >
Nakajima, T., et al. have evaluated the relationship between nailfold capillary pattern and lifestyle habits and coldness of the fingertips which may exhibit microcirculation disorder linked with pre-disease. Their study was undertaken in order to evaluate the correlation between pattern of nailfold capillaries and lifestyle habits (I), clinical experimental design for the broad study (II), and follow-up study (III). In the broad study, both men and women participated, and data were collected as questionnaires for lifestyle habits, fingertip temperatures, and images using NFC. In the follow-up study, women participants addressed the improvement in lifestyle habits after the first test, and data were re-analyzed after 1–2 weeks.
Since the fourth finger may get less damage by physical stress than the second and third fingers, the fourth finger of the left hand was selected for observation, and for any participant who had a problem with fourth finger used the fourth finger on their right hand. Nailfold capillaries were observed under a light microscope (Kekkan-Bijin, AT Co., Ltd., Osaka, Japan; region of observation 500 μm × 700 μm; magnification 320×) after application of mineral oil to reduce light reflection. Capillary images were captured using Capillary Analysis System (At Co., Ltd.). The images of nailfold capillaries were numerically analyzed for four parameters: diameter, length, width, and distance. The mean value of these parameters for each individual was used for statistical analysis. Area and sums of capillary lengths were measured using Capillary Analysis System. Representative images of nailfold capillaries showing straight and long loops, twisted or bushy loops, and non-dense and small loops are shown in Figure 3.
They summarized significantly correlated parameters of nailfold capillary morphology and lifestyle habits included the same group of principal component analysis. That is, capillary area negatively correlated with the coldness of fingertips in men aged 20–39 years; the width negatively correlated with falling asleep in men aged 20–39 years; and positively and negatively correlated with the frequency of smoking and intense exercise in men aged over 40 years, respectively (Figure 4, Lower). Additionally, in women, capillary length negatively correlated with the frequency of drinking alcohol in those aged 20–39 year; and the dot plot indicated a tendency of small length of capillary loops in the high scoring group of drinking alcohol (Figure 4, Upper).
Nakajima, T., et al.'s study might be the first report indicating a correlation between the morphology of nailfold capillaries and lifestyle habits in a non-clinical population. They are indicating that the morphology of nailfold capillaries correlated with coldness of fingertips, falling asleep, smoking, and intense exercise which were involved in car-cardiovascular phenotypes. Therefore, they concluded that the simple, inexpensive, and non-invasive method using NFC can be employed for routine health checkups everywhere even at a bedside.
< Example 3: LPS supplement improved capillary vessel and blood HbA1c level [28] >
Lipopolysaccharide (LPS) is known as an endotoxin that causes serious inflammation when it is released in the blood stream during the infection of Gram-negative bacteria. On the other hand, LPS is a substance that is universally present in the environment. It is reported also that it is not toxic when orally or trans-dermally administered, and it contributes to the activation of innate immunity [30]. From that viewpoint, one example of dietary supplement study has been reported by Nakata, Y., et al. in 2017 [28]. They used dietary supplement containing LPS in their randomized double-blind, parallel-group trial study. Used LPS was derived from Gram-negative bacteria Pantoea agglomerans (LPSp) (201.5 μg/tablet as LPS), and nailfold capillaroscopy measurement was applied to judge the effectiveness of this dietary supplement.
LPS is present in the environment by attaching to edible plants of floating in the air, and it has been recently revealed that the human immune system is controlled by ingesting LPS in the environment from diet or by breathing naturally [31]. Since LPS has been found in Chinese medicines and edible plants, Inagawa et al. [32] focused on the physiological actions of naturally ingested LPS, and the safety and effect of oral and transdermal administration were investigated.
One tablet of this LPSp supplement was composed of 25 mg of fermented wheat extract that contains 10 mg/g of LPSp (measured value was 201.5 ± 22.8 μg/tablet by ELISA). Fifty-two subjects were used in this study included males and females aged 20 years or older and 74 years or younger, and subjects were within the range of normal hematological values before the start of the study excluding oxidized LDL, IgA, and CRP (Mild abnormalities in the “Japan Society of Ningen Dock Criteria [Revised on 1 April 2014]”). For the control (n =26), the supplement replaced the LPSp (n=26) with dextrin. They used the Capillary Observation System of At Co., Ltd. for vascular observ- ation; and the capillary vessel and bloodstream in the subungual space of the left ring finger were analyzed microscopically by using the capillary bloodstream assessment system. When the number of fingertip capillary vessels that can be confirmed within the specified field was assessed as an indicator, a significant increase in the number of fingertip capillary vessels was found in the LPSp supplemented group after 3 months compared with the control group (Table 4). According to the JDS (Japan Diabetes Society) criteria, 24 subjects in the LPSp supplemented group and 20 subjects in the control group were within the borderline at the baseline in HbA1c which is a glycation marker. Including the subjects with borderline, a significant decrease in blood HbA1c was found in the LPSp supplemented group after 3 months of ingestion. That study indicates that an increase in the number of capillary vessels and antiglycative effects by the oral ingestion of LPSp were found in the healthy subjects. Thus, it was suggested that orally ingested LPSp contributed to the maintenance of normal bloodstream.
< Example 4: Fermented herbal decoction improves peripheral capillary [29] >　
Another example relating to the effect of dietary factor on nailfold capillary morphology has been reported using fermented herbal decoction by Akazawa-Kudoh, S., et al. in 2018. Reduction in performance status of skin condition is one of the serious factors determining the prognosis of post-menopausal women. The purpose of their study was to investigate whether fermented herbal decoction (FHD) could improve the performance status of post-menopausal skin condition, inspecting capillary condition especially nail stem in the 4th finger of left hand. Commercially available 80 sorts of wild herbs were prepared and extracted by 100 ml of hot water (98oC) for 3 minutes to get 10 grams of grained roasted material. The fermentation was carried out by Lactobacillus leuteria for 5 days at 40oC, and each ratio of powdered sample, lactobacilli and water were 100:50:850 (prepared by ECHIGO YAKUSOU, Ltd. Niigata, Japan). After the centrifugation of 2000 xg for 10 minutes in a room temperature and supernatant was served for FHD. A randomized semi-clinical trial was conducted to assess the nailfold capillary length and its age-related value before and after (6 and 12 months) administration of FHD, which contained GABA (g-amino butyric acid) that was produced by the fermentation procedure mentioned above. After all, FHD both via oral and derma could improve the performance status of volunteer significantly (p < 0.01). That is, FHD could increase the regeneration of the capillary of nail stem; and actual increase of the number was observed in the capillary reconstitution in a group after 12 months rather than 6 months.

4. Nailfold Capillaroscopy (NFC) and Its Application for Peripheral Artery Diagnosis

Because there have been few papers published concerning the NFC and dietary habits, we expanded the dietary habit survey into microcirculation category measured by another methods that consists of a network of small blood vessels (small arteries, arterioles, capillaries, venules, and small veins) that establish a frontier with the interstitium and with lymphatic vessels, which maintain the homeostasis of tissues as well as of the entire cardiovascular system [33,34,35]. Small arteries and arterioles ensure the delivery of nutrients and oxygen to tissues with a given perfusion pressure and according to local demand. Waste products are extracted by venules, small veins, and lymphatics, the last of which also prevents the accumulation of interstitial fluid and the development of edema [36]. Considering from the important interface as a tissue interstitium, microcirculation also contributes to local tissue immunity by allowing the adhesion and infiltration of immune cells [37]. Finally, given its small caliber, microcirculation is a favorable site for the accumulation of hemostatic plugs. Under physiological conditions, the microvascular endothelium expresses a low level of adhesion molecules that limits the adhesion of leucocytes and platelets, therefore preventing inflammation and the occurrence of thrombotic phenomena. From this viewpoint, we summarized the paralleled relationship of abnormal NFC data and PAD (peripheral artery diseases)-relating conditions as shown in Table 5.
< Example 1: The effect of vitamin D receptor activator treatment on capillary blood velocity (CBV) in CKD (chronic kidney disease) patients [38] >
This paper was included to the present review in spite of the non-healthy moderate CKD patients’ case because of nutrients effectiveness on this disease. Before this paper, Dreyer, G., et al. [43], using ergocalciferol (=vitamin D2), in a double-blind randomized trial, showed that vitamin D supplementation improves microvascular endothelial function in the skin assessed by laser Doppler flowmetry after iontophoresis of acetylcholine in patients with CKD stages 3-4. Chitalia, N., et al. [44] using cholecalciferol and Zoccali, C., et al. [45] using paricalcitol (vitamin D receptor activator = VDRA) showed similar results on macrovascular endothelial function assessed by determining flow mediated vasodilatation (FMD) in the brachial artery. Here, we summarize Lundwall, K., et al.’s study [38] of double-blind placebo-controlled randomized trial, and they aimed to investigate whether low- or high-dose treatment with a VDRA can ameliorate sympathetic activation and macro- and microvascular functions assessed by several state-of-the art methods in non-diabetic patients with moderate CKD. Thirty-six patients with a mean age of 65 years and mean estimated glomerular filtration rate of 40 ml/min/1.73 m2 were included. They found a significant decline in endothelial function after 3 months, except in the group receiving 2 μg of paricalcitol. The higher dose (2 μg) seemed to attenuate the decline in microvascular endothelial function compared with lower dose (1 mg), assessed by iontophoresis of acetylcholine (p = 0.06 for all groups, p = 0.65 for the 2 μg group) and for FMD (p = 0.006 for all groups, p = 0.54 for the 2 μg group). They also found a borderline significance (p=0.05) for improved CBV (capillary blood velocity) that was measured by NFC of the great toe in the treated group, 3 months after receiving 2 μg of paricalcitol. The higher dose (2 μg) seemed to attenuate the decline in microvascular endothelial function, assessed by iontophoresis of acetylcholine (p = 0.06 for all groups, p = 0.65 for the 2 μg group) and for FMD (p = 0.006 for all groups, p = 0.54 for the 2 μg group).
< Example 2: Dynamic nailfold videocapillaroscopy must be used for early microvascular dysfunction in obesity [39] >
It has been hypothesized that obesity is the primary cause of microvascular dysfunction, which could be a pathway to increase blood pressure and decrease insulin sensitivity. Due to the high prevalence of this metabolic disorder in the world today, Maranhao, et al. investigated which is the most appropriate videocapillaroscopic method, between nailfold and dorsal finger, to assess microvascular function in obese patients since both techniques could be used for early detection as well as for follow-up. After all, their results strongly suggest that microvascular dysfunction consequent to obesity could be better detected by dynamic nailfold videocapillaroscopy than by dorsal finger videocapillaroscopy. They could speculate the derangement on microvascular hemodynamics occurs before the diagnosis of hypertension, diabetes and other metabolic syndromes. Therefore, they advocated that NFC is the most appropriate technique to precociously assess microvascular dysfunction in obesity.
< Example 3: The Relationship Between Nailfold Microcirculation and Retinal Microcirculation in Healthy Subjects [40] >
Tian, J., et al. evaluated whether the nailfold microcirculation is associated with retinal microcirculation in healthy subjects. That is, 50 subjects without systematic and ocular diseases were enrolled. Thickness of peripapillary retinal nerve fiber layer (RNFL), vessel density (VD) of radial peripapillary capillaries (RPCs), and superficial capillary VD in macular zone were measured with optical coherence tomography angiography (OCTA) in left eyes. Nailfold microcirculation, including capillary density, avascular zones, dilated capillaries, and hemorrhages was examined on the fourth digit of each subject’s non-dominant (left) hand with NFC. They found out that nailfold capillary lower density and abnormalities are associated with reduced RNFL thickness and retinal VD. The results provide a theoretical foundation for relevant studies on ocular diseases with microvascular abnormalities and could contribute to pathogenesis understanding in the future. NFC and OCTA have the potential to identify risk factors and improve accuracy of the early diagnosis and treatment of ocular diseases, even systemic diseases with any microvascular component in clinical practice.
< Example 4: NFC and peripheral artery diseases (PAD) [41] >
NFC patterns and their related predictive value in patients with PAD have not been reported up to 2022. NFC patterns in patients with PAD are likely to be aberrant, therefore, it was hypothesized that NFC is feasible in patients with PAD attending outpatient clinics and NFC patterns are abnormal. Wijnand, J.G.J., et al. recently collected the data prospectively on three randomly selected days from patients visiting the outpatient clinic of a single vascular surgery unit between April and June 2018. All patients with a history of PAD (intermittent claudication [IC]; n=17) or chronic limb threatening ischemia [CLTI]; n=9) who consented to the procedure were eligible. Controls without a history of PAD or CLTI (n=10) were visitors accompanying the patients.
Their results showed that there were no significant abnormalities in quantitative measures, namely mean capillary diameter was within the normal reference value range [46], and mean capillary count per millimeter ± standard deviation was similar among healthy controls, IC, and CLTI groups. However, among the qualitative measures, both hemorrhages and non-specific qualitative abnormalities (ranging from disturbed capillary architecture, lower density, abnormal morphology, dilatation, areas of decreased vascularity, and atypical branching) were most prevalent in the IC group. Two observations, both prominent venous plexus (PVP) and mega-capillaries (MCs), occurred exclusively in CLTI patients. Biomarkers of endothelial dysfunction are present in CLTI [47]. In systemic sclerosis the extent of abnormalities on NFC has been linked to circulating biomarkers of inflammation and endothelial dysfunction [48], which have also been shown to be altered in CLTI. Those findings suggest that NFC abnormalities may also be used as markers for inflammation and endothelial dysfunction in PAD, although this needs to be confirmed in larger studies as they described.
< Example 5: Relationship between NFC parameters and the severity of diabetic retinopathy [42] >
Recently Okabe, et al. investigated whether non-invasive measurements of the NFC are associated with the presence and severity of diabetic retinopathy (DR) in patients with type 2 diabetes. Eighty-three eyes of 83 patients with type 2 diabetes were enrolled, and 63 age-matched non-diabetic subjects served as controls. Diabetic patients were classified by the severity of their DR: non-DR (NDR), non-proliferative DR (NPDR), and proliferative DR (PDR). They showed that 4 NFC parameters in the diabetic patients were significantly lower than in the controls (all P < 0.001); i.e., there was a statistically significant decrease in the NFC parameters along with the increasing severity of DR (number: P = 0.02; all others: P < 0.001). Logistic regression analysis revealed that combining the systemic characteristics of age, sex, systolic blood pressure, estimated glomerular filtration rate, Hb A1c level, and history of hypertension and dyslipidemia could indicate the presence of DR and PDR (the area under the receiver operating characteristic curve [AUC] = 0.81, P = 0.006; AUC = 0.87, P = 0.001, respectively). Furthermore, the discriminative power of DR was significantly improved (P = 0.03) by adding NFC length to the systemic findings (AUC = 0.89, P < 0.001). Finally, they concluded that alterations in NFC morphology, such as capillary shortening, may be closely correlated with the presence of DR (diabetic retinopathy) and PDR (proliferative DR).

5. The Role of Dietary or Nutritional Supplementation in Microcirculation

Finally, we focused on the role of dietary or nutritional supplementation in microcirculation summarized from recently published papers majorly in the USA and EU where the government-approved dietary supplement system preceded than other countries [49].
< Health claims in USA and Europe > [33,34]
Food supplements are manufactured from food, isolated nutrients, or food-derived compounds, which occur as powders, pills, potions, and other types of medication that are not commonly associated with food [50]. Due to the increasing interest shown in personal health, aging demographics, and successful personalized care products, the demand for food supplements has grown and is expected to continue [51]. Cardiovascular disease (CVD) is a significant public health concern worldwide and a leading cause of morbidity and mortality in developed countries [52,53]. In 2015, nearly one third of all deaths worldwide were caused by CVD according to the World Health Organization [54]. Therefore, the effects of cardiovascular risk and CVD on most food supplements have long since been investigated [51,55,56,57].
< American and European Legal Framework of Food Supplements >
There are different ways of classifying claims for food supplements in the USA and the EU. In the USA, there are three major categories, namely “nutrition content claims”, “structure/function claims”, and “health claims” [58]. In the EU, the three major categories are also defined as “nutrition claims”, “health claims”, and “reduction of disease risk claims” [59]. There is neither a consensus about nor overlaps between the two different classifications of USA and EU. Indeed, from the scope of Raposo, A., et al.'s review paper [33,34], it seemed adequate to consider only two types of claims, “nutritional claims” (which correspond to the EU “nutrition claims”, plus the “nutrition content claims” and “structure/function claims” in the USA) and “health claims” (which encompass the USA “health claims”, and “health claims” plus the “reduction of disease risk claims” in the EU).
Authorized health claims, approved by the FDA, USA, must comply with the so-called Significant Scientific Agreement (SSA health claims) or the Food and Drug Administration Modernization Act (FDAMA health claims). However, only SSA health claims are allowed on food supplement labels [60]. When a food supplement does not fully satisfy the SSA but is still recognized for some scientific evidence that can support its intended claim, the FDA may recognize that claim as a “qualified health claim”. Thus, it is worth knowing which food supplements may have beneficial effects on microcirculation by considering that the health claims approved by the USA, the EU, or other governments positively affect consumer choices. Although it was impossible to find any health claims directly identified with the word microcirculation in the list of claims approved by the FDA [60], some of these claims may, in fact, have direct and indirect implications for microcirculation (Table 6). This "Authorized Health Claims" contains "Dietary saturated fat and cholesterol and risk of coronary heart disease", “Fruit, vegetables and grain products that contain (dietary) fiber, particularly soluble fiber, and risk of coronary heart disease”, "Soy protein and risk of coronary heart disease", and “Plant sterol/stanol esters and risk of coronary heart disease”. "Qualified Health Claims" contains "Whole grain foods with moderated fat content and risk of heart disease", “Substitution of saturated fat in diet for unsaturated fatty acids and reduced risk of heart disease”, "B vitamins and vascular disease", “Nuts and heart disease”, "Omega 3 fatty acids and coronary heart disease", “Monounsaturated fatty acids from olive oil and coronary heart disease”, and so on (See Table 6).
Regarding the EU [61,62], the list of non-authorized claims with the word microcirculation are shown in Table 7, which can be generically considered similar to those recognized by the FDA, USA. There are five claims with specific references to the word microcirculation that were not authorized given the EFSA’s previous assessment ([63,64,65,66,67]). This list contains “Dry isoflavones soy extract”, “Niacin”, "Bioflavonoids" and "Vitamin E acetate", and oligomeric procyanidins. For example, it is described that "Bioflavonoids" has a positive effect on microcirculatory tropism by favoring the processes that protect small venous vessels. It protects the body from the harmful action of free radicals and skin from ultraviolet rays [65]; and that "Vitamin E acetate" supports microcirculation and scalp oxygenation [66].
< Dietary and lifestyle recommendation for peripheral artery disease (PAD) preven- tion [68] =2020 >
Peripheral artery disease (PAD) is defined as partial or complete stenosis of ≥≥ 1 peripheral arteries ([69,70], 2015 and 2008). PAD affects 3%-10% of the Western population and if remains untreated can have devastating consequences to patients and their families. Researchers belonging to Western countries (Greece, USA, UK, the Netherlands) published review paper entitled "Nutrition, dietary habits, and weight management to prevent and treat patients with PAD" in 2020 [68]. Their paper analyzed how healthy dietary habits can decrease PAD rates when applied in the general population, limited to artery disease and excluding renal, coronary cerebral, mesenteric, and aneurysms [70]. PAD prevalence ranges between 3%-10%, but it can be as high as 15%-20% among elderly ([71]). More than 65% of adults with PAD are overweight or obese, while 78% are characterized by deficiencies in vitamins and minerals [72]. Both suboptimal nutritional status and high fat mass have been associated with worsening of the ambulatory status and vascular health in patients with PAD and claudication [73]. Nutritional advice and weight management are of paramount significance in PAD management [74].
Sagris, M., et al. [68] summarized the dietary and lifestyle recommendations for PAD prevention. They pointed out that the habitual recommended consumptions of various nutrients and fruits, vegetables and anti-oxidants with other recommendation of lifestyle managements (regular physical activity, avoiding smoking). This recommendation includes increased consumption of omega-3 fatty acids, various B vitamins (folic acid, B6, B12), vitamin D, vitamin A, vitamin C, vitamin E; and minerals (zinc intake and sodium upper-limit). While further research attempts are anticipated, emphasis on proper nutrition, dietary interventions and weight management should be part of the PAD prevention and treatment as they described.
<Advancing beyond the "Heart-Healthy Diet" for PAD [71] =2015 >
PAD is a burdensome cardiovascular condition that results from chronic inflammatory insults to the arterial vasculature. Key risk factors include age, gender, type II diabetes mellitus, hypertension, hypercholesterolemia, hyperhomocysteinemia, smoking, lack of physical exercise and poor diet, the latter three being modifiable in the development and progression of PAD. A growing body of evidence indicates that imbalanced nutrient intake may contribute to the development and progression of PAD. In 2015 Nosova, E.V., et al. summarized nine categories of nutrients, as well as four diets endorsed by the American Heart Association (AHA) and American College of Cardiology (ACC) that may be prescribed to patients with or at risk for PAD [71]. They firstly explained the items of this National "Guidelines for Cardiovascular Disease". The 2013 AHA/ACC composite Task Force guidelines [75] address nutrition-focused risk reduction strategies for cardiovascular disease in a broad context, with the aim of improving public health. The guidelines endorse a “Heart Healthy Lifestyle" and they provide a general framework for incorporating healthy nutrition into lifestyle management to improve blood pressure and lipid control. They emphasize broad nutrient categories that are associated with better cardiovascular outcomes (eg. fruits and vegetables, whole grains, legumes, etc.), although an important limitation is that particular nutrients that may benefit patients with advanced cardiovascular disease are not explicitly identified. The most specific suggestions are embedded in recommendations for lowering low-density lipoprotein cholesterol (LDL-C): the task force advises obtaining a maximum of 5-6% of total calories from saturated fat, and minimizing intake of foods rich in trans-fats (found in milk, animal fats and some vegetable oils).
The nutrients reviewed by their paper included omega-3 polyunsaturated fatty acids (n-3 PUFAs), B vitamins (folic acid, B6, B12), and anti-oxidants. The diet plans described include the DASH (Dietary Approaches to Stop Hypertension) diet, Mediterranean diet, low-fat diet, low carbohydrate diet, Dr. Dean Ornish’s Spectrum® Diet and Dr. Andrew Weil’s Anti-Inflammatory Diet, though these latter two Diets are not recommended by national guideline [76]. Considering from "Strength of Evidence" by their paper, n-3 PUFAs (poly-unsaturated fatty acids), fatty fish, and EPA + DHA must be beneficial for primary and secondary prevention of CVD. "Reduce saturated fat intake to 5-6% of total daily caloric intake" and "daily sodium intake restriction to 2.3 grams (~ 6 grams/day salt)" also must be beneficial for prevention of CVD. "Dietary fiber intake of 14 gram/1000 kcal, or 25 g for adult women and 38 g for adult men” are also recommended for CVD prevention. The obtained findings were summarized in their paper’s Tables; which was entirely beneficial, but partly non-effective in some items.

6. The Effects of Dietary Flavonoids on Microvascular Health

Before closing, it is worthy to mention the effect of dietary flavonoids on microvascular health; because over the past two-decades, various experimental and epidemiological studies have shown that the consumption of flavonoid-rich foods is associated with a reduced risk of CVDs [77,78]. Flavonoids are a large family of over 5,000 hydroxylated polyphenolic compounds that carry out important functions in plants, including attracting pollinating insects; combating environmental stresses, such as microbial infection; and regulating cell growth [79]. Their bioavailability and biological activities in humans appear to be strongly influenced by their chemical nature.
Vascular function has been shown to be linked with cognition and brain function, with increased cardiovascular health being associated with greater cognitive performance [80,81,82]. Furthermore, many of the risk factors associated with cardiovascular health are also risk factors for cerebrovascular health, such as hypertension, hypercholesterolemia, and diabetes, with CVD itself having been identified as a risk factor for vascular dementia, caused by a reduction in blood flow to the brain [83,84]. As Rees, A., et al. reported, various flavonoids have significant effects on increasing endothelial function and peripheral blood flow, and thereafter on decreasing the risk of CVD [85,86,87,88,89,90]. Rees, A., et al. summarized the effect of flavonoids on endothelial function from the viewpoint of "flow-mediated dilation" measurement. Acute or chronic ingestions of dark chocolate flavanols, chocolate polyphenols, cocoa flavanols, apple polyphenols, black tea catechins, were mostly effective to increase in FMD (flow-mediated dilation) of peripheral arteries [91,92,93,94,95,96,97,98,99,100,101,102,103,104].
< Biological effects of epicatechin and taxifolin [105] = 2021 >
Especially, Bernatova, I. and Liskova, S. emphasized 2 typical flavonoids: epicatechin and taxifolin which benefit peripheral blood flow and endothelial function. Both epicatechin and taxifolin are naturally occurring in various fruits, vegetables, and edible tree extracts. Epicatechin is present mainly in green tea, black tea, cacao, and cacao products (cocoa and chocolate). Cacao beans are supposedly the most abundant sources of EC [106,107]. Taxifolin can be found in red onions [108], apples [109], tomatoes, sorghum grain, white grapes, strawberries, mulberries [110], acai berries, peanuts, adzuki bean, pine seeds [111], thyme, and citrus fruits [112]. Taxifolin is also present in a high concentration in conifers such as French maritime bark, Siberian larch, Korean red pine, cedar deodar, Indian pine and Chinese yew, from which it can be industrially produced. Both epicatechin and taxifolin are also broadly available in various commercially available food supplements.
We briefly summarize the examples of the biological effects of (−)-epicatechin as well as (+)-taxifolin and/or (−)-taxifolin that were found in the experimental models and that may be relevant for the treatment of hypertension and viral infection through improvements of peripheral vascular function and anti-inflammatory activity as shown in Bernatova and Liskova’s paper [105], and references of peripheral vascular function, cardioprotective- and anti-inflammatory effects were summarized in Table 8 [105,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137]. References of cellular and molecular mechanisms underlying the biological effects of epicatechin and taxifolin are listed in Table 9 [105,113,117,121,126,128,138,139,140,141,142,143,144,145,146,147,148,149,150], and these two flavonoids are effective in ROS (reactive oxygen species) reduction, antioxidant enzymes activation, endothelial NO elevation, and NF-kB reduction.

7. Conclusion and Prospects

In the past decade, the morphological changes in the nailfold capillary have been reported in the unhealthy lifestyle habits such as smoking, inappropriate diets, sleep shortage, and even psychological stress which presents slow blood flow. Therefore, study in the relationships between the morphology of nailfold capillaries and lifestyle habits has high potential to understand the unhealthy state, or even predict the pre-disease condition. So, simple, inexpensive, and non-invasive methods such as NFC are constantly needed for routine health checkups. Thus, we undertook a systematic search in PubMed database, and summarized the studies reporting the assessment of morphological NFC in order to undertake a comprehensive review on the usefulness of NFC not only in clinical diagnosis, but also in unhealthy dietary lifestyle improvements.
Because there was a paralleled relationship of abnormal NFC data and peripheral artery diseases (PAD)-relating conditions, we summarized the health claims information from recently published papers in the USA and EU where the government-approved dietary supplement system preceded than other countries, in order to overview the role of dietary or nutritional supplementation in healthy microvascular blood flow and endothelial function.
Here in this review paper, we finally summarized the dietary and lifestyle health promotion strategy judging from NFC- and the other relating-measurement from the viewpoint of microvascular blood flow and endothelial function. However, the dietary interventional studies with flavonoids or other functional nutrients are still necessary to understand the whole mechanisms of flavonoids or nutrients actions in our body; hopefully using pre-symptomatic subjects with NFC monitoring.
Especially, recent researches suggest that not only essential nutrients, but also flavonoids and other functional food components are able to exhibit cardio- and neuro-protective effects, as demonstrated with improvements in both of peripheral blood flow and endothelial function, which benefit body health. However, the dietary interventional studies with flavonoids, nutrients, and other functional food components are still necessary to understand those mechanisms in our body; hopefully using pre-symptomatic subjects with NFC monitoring.

Author Contributions

Conceptualization, M.K. and D.T.; methodology, D.T., J.N., C.F.; software, J.N., C.F.; investigation, M.K., D.T., J.N., C.F.; resources, M.K., D.T.; writing—original draft preparation, M.K.; writing—review and editing, D.T., Y.O., H.S.; supervision, M.K., D.T., H.S.; project administration, D.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Informed Consent Statement

Not applicable.

Acknowledgments

The authors thank the Capillary Laboratory and Social Implementation Consortium for their contribution to the manuscript charge payment.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Smith, V.; Herrick, A.L.; Ingegnoli, F.; Damjanov, N.; De Angelis, R.; Denton, C.P.; Distler, O.; Espejo, K.; Foeldvari, I.; Frech, T.; et al. Standardization of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimm. Rev. 2020, 19, 102458. [Google Scholar] [CrossRef] [PubMed]
  2. Van Den Hoogen, F.; Khanna, D.; Franzen, J.; Johnson, S.R.; Baron, M.; Tyndall, A.; Matucci-Cerinic, M.; Naden, R.P.; Medsger Jr., T. A.; Carreira, P.E.; et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013, 65, 2737–2747. [Google Scholar] [CrossRef] [PubMed]
  3. Dima, A.; Berza, I.; Popescu, D.N.; Parvu, M.I. Nailfold capillaroscopy in systemic diseases: short overview for internal medicine. Rom. J. Intern. Med. 2021, 59, 201–217. [Google Scholar] [CrossRef] [PubMed]
  4. Cutolo, M. Atlas of capillaroscopy in rheumatic diseases. Elsevier 2010, 25–43. [Google Scholar]
  5. Cutolo, M.; Sullia, A.; Smith, V. How to perform and interpret capillaroscopy. Best Pract. Res. Clin. 2013, 27, 237–248. [Google Scholar] [CrossRef] [PubMed]
  6. Chojnowski, M.M.; Felis-Giemza, A. ; Olesinska Capillaroscopy – A role in modern rheumatology. Reumatologia 2016, 54, 67–72. [Google Scholar] [CrossRef] [PubMed]
  7. [12] Mansueto, N.; Rotondo, C.; Corrado, A.; Cantatore, F.P. Nailfold capillaroscopy: a comprehensive review on common findings and clinical usefulness in non-rheumatic disease. J. Med. Invest. 2021, 68, 6–14. [Google Scholar] [CrossRef] [PubMed]
  8. Grassi, W.; De Angelis, R. Capillaroscopy: questions and answers. Clin. Rheumatol. 2009, 26, 2009–2016. [Google Scholar] [CrossRef] [PubMed]
  9. Ciaffi, J.; Nerenxa Ajasllari, N.; Mancarella, L.; Brus, V.; Riccardo Meliconi, R.; Ursini, F. Nailfold capillaroscopy in common non-rheumatic conditions. Microvascular Res. 2020, 131, 104036. [Google Scholar] [CrossRef]
  10. Maldonado, G.; Rios, C. Nailfold capillaroscopy in diabetes mellitus Potential technique for the microvasculature evaluation. Endocrinol. & Metabol. Syndrome 2017, 6, e125. [Google Scholar]
  11. Maldonado, G.; Guerrero, R.; Paredes, C.; Ríos, C. Nailfold capillaroscopy in diabetes mellitus. Microvasc. Res. 2017, 112, 41–46. [Google Scholar] [CrossRef] [PubMed]
  12. Kayser, C.; Bredemeir, M.; Caleiro, M.T.; Capobianco, K.; Fernandes, T.M.; De Araujo Fontenele, S.M.; et al. Position article and guidelines 2018 recommendations of the Brazilian Society of Rheumatology for the indication, interpretation and performance of nailfold capillaroscopy. Adv. Rheumatol., 2019, 59, 1–13. [Google Scholar] [CrossRef] [PubMed]
  13. Emrani, Z.; Karbalaie, A.; Fatemi, A.; Etehadtavakol, M.; Erlandsson, B.E. Capillary density: An important parameter in nailfold capillaroscopy. Microvasc. Res. 2017, 109, 7–18. [Google Scholar] [CrossRef] [PubMed]
  14. Tavakol, M.E.; Fatemi, A.; Karbalaie, A.; Emrani, Z.; Erlandsson, B.E. Nailfold capillaroscopy in rheumatic diseases: which parameters should be evaluated? Res. Int. 2015, 974530. [Google Scholar]
  15. Roldán, L.M.C.; Franco, C.J.V.; Navas, M.A.M. Capillaroscopy in systemic sclerosis: A narrative literature review. Rev. Colomb. Reumatol. 2016, 23, 250–258. [Google Scholar]
  16. Ingegnoli, F.; Gualtierotti, R.; Lubatti, C.; Bertolazzi, C.; Gutierrez, M.; Boracchi, P. , et al. Nailfold capillary patterns in healthy subjects: A real issue in capillaroscopy. Microvasc. Res. 2013, 90, 90–95. [Google Scholar] [CrossRef] [PubMed]
  17. Faggioli, P.; Tamburello, A.; Sciascera, A.; Gilardi, A.G.; Mazzone, A. Nailfold videocapillaroscopy in internal medicine. Ital. J. Med. 2015, 9, 234–242. [Google Scholar] [CrossRef]
  18. Kayser, C.; Sekiyama, J.Y.; Próspero, L.C.; Camargo, C.Z.; Andrade, L.E.C. Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis. Clin Exp Rheumatol. 2013, 31 (SUPPL.76), S103–S108. [Google Scholar]
  19. Cutolo, M.; Melsens, K.; Wijnant, S.; Ingegnoli, F.; Thevissen, K.; Keyser, F.D.; et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmun. Rev. 2018, 17, 344–352. [Google Scholar] [CrossRef]
  20. Doughty, K.N.; Del Pilar, N.X.; Audette, A.; Katz, D.L. Lifestyle medicine and the management of cardiovascular disease. Curr. Cardiol. Rep. 2017, 19, 116. [Google Scholar] [CrossRef]
  21. Kerschbaum, E.; Nu¨ssler, V. Cancer Prevention with Nutrition and Lifestyle. Visc. Med. 2019, 35, 204–209. [Google Scholar] [CrossRef] [PubMed]
  22. Zheng, Y.; Ley, S.H.; Hu, F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Rev. Endocrinol. 2018, 88–98. [Google Scholar] [CrossRef] [PubMed]
  23. Kivipelto, M.; Mangialasche, F.; Ngandu, T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nature Rev. Neurol. 2018, 14, 653–666. [Google Scholar] [CrossRef] [PubMed]
  24. Yuksel, E.P.; Yuksel, S.; Soylu, K.; Aydin, F. Microvascular abnormalities in asymptomatic chronic smokers: A video capillaroscopic study. Microvasc Res. 2019, 124, 51–53. [Google Scholar] [CrossRef] [PubMed]
  25. Toyoda, M.; Harada, Y.; Masuda, N.; Matsuki, Y.; Urakami, S.; Kobayashi, K.; et al. Research on the Relationship Between Blood Flow by Microscope and the Lifestyle Mainly in Female University Students. Proceeding Jissen Women’s Univ. Fac. Hum. Life Sci. 2012, 49, 183–189. [Google Scholar]
  26. Gorasiya, A.R.; Mehta, H.H.; Prakashey, A.; Dave, M. Nailfold capillaroscopy of healthy individuals--An observational study. Indian Dermatol. Online J. 2022, 13, 600–605. [Google Scholar] [CrossRef] [PubMed]
  27. Nakajima, T.; Nakano, S.; Kikuchi, A.; Matsunaga, Y. Nailfold capillary patterns correlate with age, gender, lifestyle habits, and fingertip temperature. PLoS ONE 2022, 17, e0269661. [Google Scholar] [CrossRef] [PubMed]
  28. Nakata, Y.; Kohchi, C.; Ogawa, K.; Nakamoto, T.; Yoshimura, H.; Soma, G. Effects of 3 months Continuous intake of supplement containing Pantoea agglomerans LPS to maintain normal bloodstream in adults: Parallel double-blind randomized controlled study. Food Sci. Nutr. 2017, 6, 197–206. [Google Scholar] [CrossRef] [PubMed]
  29. Akazawa-Kudoh, S.; Fujimoto, Y.; Sawada, M.; Takeno, D.; Yamaguchi, N. Fermented Herbal Decoction Improves a Performance Status of Skin Conditions by Reconstituting Peripheral Capillary. E-Cronicon Gynaecol. 2018, 7, 284–292. [Google Scholar]
  30. Inagawa, H.; Kohchi, C.; Soma, G. Oral administration of lipopolysaccharides for the prevention of various disease: Benefit and usefulness. Anticancer Res. 2011, 31, 2431–2436. [Google Scholar]
  31. Braun-Fahrländer, C.; Riedler, J.; Herz, U.; Eder, W.; Waser, M.; Grize, L. Allergy and Endotoxin Study Team: Environmental exposure to endotoxin and its relation to asthma in school-age children. New England J. of Med. 2002, 347, 869–877. [Google Scholar] [CrossRef] [PubMed]
  32. Inagawa, H.; Nishizawa, T.; Tsukioka, D.; Suda, T.; Chiba, Y.; Okutomi, T.; Morikawa, A.; Soma, G.I.; Mizuno, D. Homeostasis as regulated by activated macrophage. II. LPS of plant origin other than wheat flour and their concomitant bacteria. Chem. Pharm. Bull. (Tokyo) 1992, 40, 994–997. [Google Scholar] [CrossRef] [PubMed]
  33. Raposo, A.; Saraiva, A.; Ramos, F.; Carrascosa, C.; Raheem, D.; Bárbara, R.; Henrique Silva, H. The Role of Food Supplementation in Microcirculation—A Comprehensive Review. Biology 2021, 10, 616. [Google Scholar] [CrossRef] [PubMed]
  34. Raposo, A.; Saraiva, A.; Ramos, F.; Carrascosa, C.; Raheem, D.; Bárbara, R.; Henrique Silva, H. Correction: Raposo et al. The Role of Food Supplementation in Microcirculation—A Comprehensive Review. Biology 2021, 10, 616. Biology 2023, 12, 1198. [Google Scholar] [CrossRef] [PubMed]
  35. Guven, G.; Hilty, M.P.; Ince, C. Microcirculation: Physiology, Pathophysiology, and Clinical Application. Blood Purif. 2020, 49, 143–150. [Google Scholar] [CrossRef] [PubMed]
  36. Ince, C.; Mayeux, P.R.; Nguyen, T.; Gomez, H.; Kellum, J.A.; Ospina-Tascón, G.A.; Hernandez, G.; Murray, P.; De Backer, D. The Endothelium in Sepsis. Shock 2016, 45, 259–270. [Google Scholar] [CrossRef]
  37. McCarron, J.G.; Lee, M.D.; Wilson, C. The Endothelium Solves Problems That Endothelial Cells Do Not Know Exist. Trends Pharmacol. Sci. 2017, 38, 322–338. [Google Scholar] [CrossRef] [PubMed]
  38. Lundwall, K.; Jörneskog, G.; Jacobson, S.H.; Spaak, J. Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial. Am. J. Nephrol. 2015, 42, 265–273. [Google Scholar] [CrossRef]
  39. Maranhão; P. A., Coelho de Souza, M. das G.; Kraemer-Aguiar, L. G.; Bouskela. E. Dynamic nailfold videocapillaroscopy may be used for early microvascular dysfunction in obesity. Microvasc. Res., 2016, 106, 31–35. [Google Scholar] [CrossRef]
  40. Tian, J.; Xie, Y.; Li, M.; Oatts, J.; Han, Y.; Yang, Y.; Shi, Y.; Sun, Y.; Sang, J.; Cao, K.; Xin, C.; Labisi Siloka, L.; Wang, H.; and Wang, N. The Relationship Between Nailfold Microcirculation and Retinal Microcirculation in Healthy Subjects. Front. Physiol., 2020, 11, article 880. [Google Scholar] [CrossRef]
  41. Wijnand, J.G.J.; van Rhijn-Brouwer, F.C.C.; Spierings, J.; Teraa, M.; de Borst, G.J.; Verhaar, M.C. Naiflold capillaroscopy in patients with peripheral artery disease of the lower limb (CAPAD Study). Eur. J. Vasc. Endovasc. Surg. 2022, 63, 900–901. [Google Scholar] [CrossRef] [PubMed]
  42. Okabe, T.; Kunikata, H.; Yasuda, M.; Kodama, S.; Maeda, Y.; Nakano, J.; Takeno, D.; Fuse, N.; Nakazawa, T. Relationship between nailfold capillaroscopy parameters and the severity of diabetic retinopathy. Graefe's Archive for Clinic. and Experiment. Ophthalmol. 2024, 262, 759–768. [Google Scholar] [CrossRef] [PubMed]
  43. Dreyer, G.; Tucker, A.T.; Harwood, S.M.; Pearse, R.M.; Raftery, M.J.; Yaqoob, M.M. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin D deficiency: an exploratory, double blind, randomised controlled trial. PLoS One 2014, 9, e99461. [Google Scholar]
  44. Chitalia, N.; Ismail, T.; Tooth, L.; Boa, F.; Hampson, G.; Goldsmith, D.; Kaski, J.C.; Banerjee, D. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients. PLoS One 2014, 9, e91363. [Google Scholar] [CrossRef] [PubMed]
  45. Zoccali, C.; Curatola, G.; Panuccio, V.; Tripepi, R.; Pizzini, P.; Versace, M.; Bolignano, D.; Cutrupi, S.; Politi, R.; Tripepi, G.; et al. Paricalcitol and endothelial function in chronic kidney disease trial. Hypertension 2014, 64, 1005–1011. [Google Scholar] [CrossRef]
  46. Tavakol, M.; Fatemi, A.; Karbalaie, A.; Emrani, Z.; Erlandsson, B. Nailfold capillaroscopy in rheumatic diseases: which parameters should be evaluated? Biomed. Res. Int. 2015, 2015, 974530. [Google Scholar]
  47. Teraa, M.; Sprengers, R.W.; Westerweel, P.E.; Gremmels, H.; Goumans, M.J.; Teerlink, T.; et al. JUVENTAS study group. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One 2013, 8e55592. [Google Scholar]
  48. Avouac, J.; Vallucci, M.; Smith, V. Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. Arthritis Res. Ther. 2013, 15, R55. [Google Scholar] [CrossRef]
  49. Djaoudene, O.; Romano, A.; Bradai, Y.D.; Zebiri, F.; Amina Ouchene, A.; et al. A Global Overview of Dietary Supplements: Regulation, Market Trends, Usage during the COVID-19 Pandemic, and Health Effects. Nutrients, 2023, 15, 3320. [Google Scholar] [CrossRef]
  50. Zeisel, S.H. Regulation of “Nutraceuticals”. Science 1999, 285, 1853–1855. [Google Scholar] [CrossRef]
  51. Bronzato, S.; Durante, A. Dietary Supplements and Cardiovascular Diseases. Int. J. Prev. Med. 2018, 9, 80. [Google Scholar]
  52. Deaton, C. , Froelicher E.S., Wu L.H., Ho C., Shishani K., Jaarsma T. The Global Burden of Cardiovascular Disease. Eur. J. Cardiovasc. Nurs. 2011, 10, S5–S13. [Google Scholar] [CrossRef]
  53. Lozano, R. , Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., Abraham J., Adair T., Aggarwal R., Ahn S.Y., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2095–2128. [Google Scholar] [PubMed]
  54. World Health Organization. Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third Who Report on Neglected Tropical Diseases 2015. WHO; Geneva, Switzerland: 2015.
  55. Baumgartner, S.; Bruckert, E.; Gallo, A.; Plat, J. The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management. Atherosclerosis. Atherosclerosis 2020, 311, 116–123. [Google Scholar] [CrossRef]
  56. Vasquez, E.C.; Pereira, T.M.C.; Peotta, V.A.; Baldo, M.P.; Campos-Toimil, M. Review Article Probiotics as Beneficial Dietary Supplements to Prevent and Treat Cardiovascular Diseases: Uncovering Their Impact on Oxidative Stress. Oxid. Med. Cell. Longev. 2019, 2019, 3086270. [Google Scholar] [CrossRef]
  57. Khan, S.U.; Khan, M.U.; Riaz, H.; Valavoor, S.; Zhao, D.; Vaughan, L. Annals of Internal Medicine Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes. Ann. Intern. Med. 2019, 171, 190–198. [Google Scholar] [CrossRef] [PubMed]
  58. FDA. Label Claims for Conventional Foods and Dietary Supplements 2019. Available online: https://www.fda.gov/food/food-labeling-nutrition/label-claims-conventional-foods-and-dietary-supplements.
  59. The European Parliament and the Council of the European Union Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Off. J. Eur. Union 2006, L136, 1–40.
  60. Rocha, T.; Amaral, J.S.; Oliveira, M.B.P.P. Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review. Compr. Rev. Food Sci. Food Saf. 2016, 15, 43–62. [Google Scholar] [CrossRef] [PubMed]
  61. 61. The European Commission. Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health. Off. J. Eur. Union, 16 May.
  62. Nutrition and Health Claims. EU Register of Nutrition and Health Claims. 2018. Available online: https://ec.europa.eu/food/safety/labelling_nutrition/claims/register/public/?event=register.home.
  63. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), -------- to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J., 2011, 9, 2264.
  64. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to niacin and energy-yielding metabolism (ID 43, 49, 54), -------- to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J., 2009, 7, 1224.
  65. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to: Flavonoids and ascorbic acid in fruit juices, including berry juices (ID 1186); flavonoids from citrus (ID 1471); -------- to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J., 2011, 9, 2082.
  66. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to vitamin E and protection of DNA, proteins and lipids from oxidative damage (ID 160, 162, 1947), -------- to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2010, 8, 1816. [Google Scholar] [CrossRef]
  67. Globe Newswire Dietary Supplements Market Size, Share & Trends Analysis Report by Ingredient (Vitamins, Minerals), By Form, By Application, By End User, By Distribution Channel, By Region, and Segment Forecasts, 2020–2027. 2020.
  68. Sagris, M.; Kokkinidis, D.G.; Lempesis, I.G.; Giannopoulos, S.; Rallidis, L.; Mena-Hurtado, C.; Bakoyiannis, C. Nutrition, dietary habits, and weight management to prevent and treat patients with peripheral artery disease. Rev. Cardiovasc. Med. 2020, 21, 565–575. [Google Scholar] [PubMed]
  69. Criqui, M.H.; Aboyans, V. Epidemiology of peripheral artery disease. Circulation Res. 2015, 116, 1509–1526. [Google Scholar] [PubMed]
  70. Hiatt, W.R.; Goldstone, J.; Smith Jr., S. C.; McDermott, M.; Moneta, G.; Roberta Oka, R.; Anne B Newman, A.B.; William H Pearce, W.H. American Heart Association Writing Group 1.: Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 2008, 118, 2826–2829. [Google Scholar] [CrossRef] [PubMed]
  71. Nosova, E.V.; Conte, M.S.; Grenon, S.M. Advancing beyond the “heart-healthy diet” for peripheral arterial disease. J. of Vascul. Surg. 2015, 61, 265–274. [Google Scholar] [CrossRef]
  72. Thomas, J.; Delaney, C.; Suen, J.; Miller, M. Nutritional status of patients admitted to a metropolitan tertiary care vascular surgery unit. Asia Pacific J. of Clin. Nutr. 2019, 28, 64–71. [Google Scholar]
  73. Gardner, A.W.; Bright, B.C.; Ort, K.A.; Montgomery, P.S. Dietary intake of participants with peripheral artery disease and claudication. Angiology 2011, 62, 270–275. [Google Scholar] [CrossRef] [PubMed]
  74. Hirsch, A.T.; Criqui, M.H.; Treat-Jacobson, D.; Regensteiner, J.G.; Creager, M.A.; Olin, J.W.; Krook, S. H.; Hunninghake, D.B.; Comerota, A.J.; Walsh, M.E.; McDermott, M.M.; Hiatt, W.R. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286, 1317–1324. [Google Scholar] [CrossRef]
  75. Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; Hubbard, V.S.; de Jesus, J.M.; Lee, I.M.; et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129, S76–99. [Google Scholar] [CrossRef]
  76. Eilat-Adar, S.; Sinai, T.; Yosefy, C. , Henkin, Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients 2013, 5, 3646–3683. [Google Scholar] [CrossRef] [PubMed]
  77. Rees, A.; Georgina, F.; Dodd, G.F; Spencer, J.P.E. The Effects of Flavonoids on Cardiovascular Health: A Review of Human Intervention Trials and Implications for Cerebrovascular Function. Nutrients 2018, 10, 1852. [Google Scholar] [CrossRef] [PubMed]
  78. Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des. 2009, 15, 1072–1084. [Google Scholar] [CrossRef] [PubMed]
  79. Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: an overview. Scientific World J. 2013, 2013, 162750. [Google Scholar] [CrossRef] [PubMed]
  80. Crichton, G.E.; Elias, M.F.; Davey, A.; Alkerwi, A. Cardiovascular health and cognitive function: The Maine-Syracuse longitudinal study. PLoS ONE 2014, 9, e89317. [Google Scholar] [CrossRef] [PubMed]
  81. Gardener, H.; Wright, C.B.; Dong, C.; Cheung, K.; DeRosa, J.; Nannery, M.; Stern, Y.; Elkind, M.S.; Sacco, R.L. Ideal cardiovascular health and cognitive aging in the northern Manhattan study. J. Am. Heart Assoc. 2016, 5, e002731. [Google Scholar] [CrossRef] [PubMed]
  82. Samieri, C.; Perier, M.C.; Gaye, B.; Proust-Lima, C.; Helmer, C.; Dartigues, J.F.; Berr, C.; Tzourio, C.; Empana, J.P. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA 2018, 320, 657–664. [Google Scholar] [CrossRef] [PubMed]
  83. Knopman, D.; Boland, L.L.; Mosley, T.; Howard, G.; Liao, D.; Szklo, M.; McGovern, P.; Folsom, A.R. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56, 42–48. [Google Scholar] [CrossRef]
  84. Vicario, A.; Cerezo, G.H. At the heart of brain disorders—Preventing cognitive decline and dementia. Eur. Cardiol. Rev. 2015, 10, 60–63. [Google Scholar] [CrossRef]
  85. McCullough, M.L.; Peterson, J.J.; Patel, R.; Jacques, P.F.; Shah, R.; Dwyer, J.T. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of us adults. Am. J. Clin. Nutr. 2012, 95, 454–464. [Google Scholar] [CrossRef]
  86. Mink, P.J.; Scrafford, C.G.; Barraj, L.M.; Harnack, L.; Hong, C.P.; Nettleton, J.A.; Jacobs, D.R., Jr. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85, 895–909. [Google Scholar] [CrossRef] [PubMed]
  87. Wang, X.; Ouyang, Y.Y.; Liu, J.; Zhao, G. Flavonoid intake and risk of cvd: A systematic review and meta-analysis of prospective cohort studies. Br. J. Nutr. 2014, 111, 1–11. [Google Scholar] [CrossRef] [PubMed]
  88. Cassidy, A.; O’Reilly, E.J.; Kay, C.; Sampson, L.; Franz, M.; Forman, J.P.; Curhan, G.; Rimm, E.B. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 2011, 93, 338–347. [Google Scholar] [CrossRef]
  89. Mursu, J.; Voutilainen, S.; Nurmi, T.; Tuomainen, T.P.; Kurl, S.; Salonen, J.T. Flavonoid intake and the risk of ischaemic stroke and cvd mortality in middle-aged Finnish men: The kuopio ischaemic heart disease risk factor study. Br. J. Nutr. 2008, 100, 890–895. [Google Scholar] [CrossRef]
  90. Peterson, J.J.; Dwyer, J.T.; Jacques, P.F.; McCullough, M.L. Associations between flavonoids and cardiovascular disease incidence or mortality in European and us populations. Nutr. Rev. 2012, 70, 491–508. [Google Scholar] [CrossRef] [PubMed]
  91. Sansone, R.; Rodriguez-Mateos, A.; Heuel, J.; Falk, D.; Schuler, D.; Wagstaff, R.; Kuhnle, G.G.; Spencer, J.P.; Schroeter, H.; Merx, M.W.; et al. Cocoa flavanol intake improves endothelial function and framingham risk score in healthy men and women: A randomised, controlled, double-masked trial: The flaviola health study. Br. J. Nutr. 2015, 114, 1246–1255. [Google Scholar] [CrossRef] [PubMed]
  92. Faridi, Z.; Njike, V.Y.; Dutta, S.; Ali, A.; Katz, D.L. Acute dark chocolate and cocoa ingestion and endothelial function: A randomized controlled crossover trial. Am. J. Clin. Nut. 2008, 88, 58–63. [Google Scholar] [CrossRef] [PubMed]
  93. Engler, M.B.; Engler, M.M.; Chen, C.Y.; Malloy, M.J.; Browne, A.; Chiu, E.Y.; Kwak, H.K.; Milbury, P.; Paul, S.M.; Blumberg, J.; et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr. 2004, 23, 197–120. [Google Scholar] [CrossRef] [PubMed]
  94. Dower, J.I.; Geleijnse, J.M.; Kroon, P.A.; Philo, M.; Mensink, M.; Kromhout, D.; Hollman, P.C. Does epicatechin contribute to the acute vascular function effects of dark chocolate? A randomized, crossover study. Mol. Nutr. Food Res. 2016, 60, 2379–2386. [Google Scholar] [CrossRef]
  95. Fisher, N.D.; Hollenberg, N.K. Aging and vascular responses to flavanol-rich cocoa. J. Hypertens. 2006, 24, 1575–1580. [Google Scholar] [CrossRef]
  96. Bondonno, C.P.; Yang, X.; Croft, K.D.; Considine, M.J.; Ward, N.C.; Rich, L.; Puddey, I.B.; Swinny, E.; Mubarak, A.; Hodgson, J.M. Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: A randomized controlled trial. Free Radic. Biol. Med. 2012, 52, 95–102. [Google Scholar] [CrossRef] [PubMed]
  97. Bondonno, N.P.; Bondonno, C.P.; Blekkenhorst, L.C.; Considine, M.J.; Maghzal, G.; Stocker, R.; Woodman, R.J.; Ward, N.C.; Hodgson, J.M.; Croft, K.D. Flavonoid-rich apple improves endothelial function in individuals at risk for cardiovascular disease: A randomized controlled clinical trial. Mol. Nutr. Food Res. 2017, 62. [Google Scholar] [CrossRef] [PubMed]
  98. Grassi, D.; Mulder, T.P.; Draijer, R.; Desideri, G.; Molhuizen, H.O.; Ferri, C. Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. J. Hypertens. 2009, 27, 774–781. [Google Scholar] [CrossRef] [PubMed]
  99. Schreuder, T.H.; Eijsvogels, T.M.; Greyling, A.; Draijer, R.; Hopman, M.T.; Thijssen, D.H. Effect of black tea consumption on brachial artery flow-mediated dilation and ischaemia-reperfusion in humans. Appl. Physiol. Nutr. Metab. 2014, 39, 145–151. [Google Scholar] [CrossRef]
  100. Schroeter, H.; Heiss, C.; Balzer, J.; Kleinbongard, P.; Keen, C.L.; Hollenberg, N.K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H.H.; Kelm, M. (-)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA 2006, 103, 1024–1029. [Google Scholar] [CrossRef] [PubMed]
  101. Marsh, C.E.; Carter, H.H.; Guelfi, K.J.; Smith, K.J.; Pike, K.E.; Naylor, L.H.; Green, D.J. Brachial and cerebrovascular functions are enhanced in postmenopausal women after ingestion of chocolate with a high concentration of cocoa. J. Nutr. 2017, 147, 1686–1692. [Google Scholar] [CrossRef]
  102. Jochmann, N.; Lorenz, M.; Krosigk, A.; Martus, P.; Bohm, V.; Baumann, G.; Stangl, K.; Stangl, V. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br. J. Nutr. 2008, 99, 863–868. [Google Scholar] [CrossRef] [PubMed]
  103. Duffy, S.J.; Keaney, J.F., Jr.; Holbrook, M.; Gokce, N.; Swerdloff, P.L.; Frei, B.; Vita, J.A. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104, 151–156. [Google Scholar] [CrossRef]
  104. Grassi, D.; Draijer, R.; Schalkwijk, C.; Desideri, G.; D’Angeli, A.; Francavilla, S.; Mulder, T.; Ferri, C. Black tea increases circulating endothelial progenitor cells and improves flow mediated dilatation counteracting deleterious effects from a fat load in hypertensive patients: A randomized controlled study. Nutrients 2016, 8, 727. [Google Scholar] [CrossRef]
  105. Bernatova, I. and Liskova, S. Mechanisms modified by (-)-epicatechin and taxifolin relevant for the treatment of hypertension and viral infection: Knowledge from preclinical studies. Antioxidants (Basel). 2021, 10, 467. [Google Scholar] [CrossRef]
  106. Miller, K.B.; Hurst, W.J.; Flannigan, N.; Ou, B.; Lee, C.Y.; Smith, N.; Stuart, D.A. Survey of commercially available chocolate- and cocoa-containing products in the United States. 2. Comparison of flavan-3-ol content with nonfat cocoa solids, total polyphenols, and percent cacao. J. Agric. Food Chem. 2009, 57, 9169–9180. [Google Scholar] [CrossRef]
  107. Alanon, M.E.; Castle, S.M.; Siswanto, P.J.; Cifuentes-Gomez, T.; Spencer, J.P. Assessment of flavanol stereoisomers and caffeine and theobromine content in commercial chocolates. Food Chem. 2016, 208, 177–184. [Google Scholar] [CrossRef] [PubMed]
  108. Slimestad, R.; Fossen, T.; Vågen, I.M. Onions: A source of unique dietary flavonoids. J. Agric. Food Chem. 2007, 55, 10067–10080. [Google Scholar] [CrossRef] [PubMed]
  109. Vega-Villa, K.R.; Remsberg, C.M.; Takemoto, J.K.; Ohgami, Y.; Yáñez, J.A.; Andrews, P.K.; Davies, N.M. Stereospecific pharmacokinetics of racemic homoeriodictyol, isosakuranetin, and taxifolin in rats and their disposition in fruit. Chirality 2011, 23, 339–348. [Google Scholar] [CrossRef] [PubMed]
  110. Zhang, W.; Han, F.; He, J.; Duan, C. HPLC-DAD-ESI-MS/MS analysis and antioxidant activities of nonanthocyanin phenolics in mulberry (Morus alba L.). J. Food Sci. 2008, 73, C512–C518. [Google Scholar] [CrossRef] [PubMed]
  111. Lantto, T.A.; Dorman, H.J.D.; Shikov, A.N.; Pozharitskaya, O.N.; Makarov, V.G.; Tikhonov, V.P.; Hiltunen, R.; Raasmaja, A. Chemical composition, antioxidative activity and cell viability effects of a Siberian pine (Pinus sibirica Du Tour) extract. Food Chem. 2009, 112, 936–943. [Google Scholar] [CrossRef]
  112. Gerhäuser, C. Beer constituents as potential cancer chemopreventive agents. Eur. J. Cancer 2005, 41, 1941–1954. [Google Scholar] [CrossRef]
  113. Kluknavsky, M.; Balis, P.; Puzserova, A.; Radosinska, J.; Berenyiova, A.; Drobna, M.; Lukac, S.; Muchova, J.; Bernatova, I. (−)-Epicatechin prevents blood pressure increase and reduces locomotor hyperactivity in young spontaneously hypertensive rats. Oxid. Med. Cell. Longev. 2016, 2016, 6949020. [Google Scholar] [CrossRef]
  114. Garate-Carrillo, A.; Navarrete-Yañez, V.; Ortiz-Vilchis, P.; Guevara, G.; Castillo, C.; Mendoza-Lorenzo, P.; Ceballos, G.; Ortiz-Flores, M.; Najera, N.; Bustamante-Pozo, M.M.; et al. Arginase inhibition by (−)-epicatechin reverses endothelial cell aging. Eur. J. Pharmacol. 2020, 885, 173442. [Google Scholar] [CrossRef]
  115. Galleano, M.; Bernatova, I.; Puzserova, A.; Balis, P.; Sestakova, N.; Pechanova, O.; Fraga, C.G. (−)-Epicatechin reduces blood pressure and improves vasorelaxation in spontaneously hypertensive rats by NO-mediated mechanism. IUBMB Life 2013, 65, 710–715. [Google Scholar] [CrossRef]
  116. Aggio, A.; Grassi, D.; Onori, E.; D’Alessandro, A.; Masedu, F.; Valenti, M.; Ferri, C. : Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols. Eur. J. Nutr. 2013, 52, 263–272. [Google Scholar] [CrossRef] [PubMed]
  117. MacRae, K.; Connolly, K.; Vella, R.; Fenning, A. Epicatechin’s cardiovascular protective effects are mediated via opioid receptors and nitric oxide. Eur. J. Nutr. 2019, 58, 515–527. [Google Scholar] [CrossRef] [PubMed]
  118. Novakovic, A.; Marinko, M.; Vranic, A.; Jankovic, G.; Milojevic, P.; Stojanovic, I.; Nenezic, D.; Ugresic, N.; Kanjuh, V.; Yang, Q.; et al. Mechanisms underlying the vasorelaxation of human internal mammary artery induced by (−)-epicatechin. Eur. J. Pharmacol. 2015, 762, 306–312. [Google Scholar] [CrossRef]
  119. Marinko, M.; Jankovic, G.; Nenezic, D.; Milojevic, P.; Stojanovic, I.; Kanjuh, V.; Novakovic, A. (−)-Epicatechin-induced relaxation of isolated human saphenous vein: Roles of K+ and Ca2+ channels. Phytother. Res. 2018, 32, 267–275. [Google Scholar] [CrossRef]
  120. Plotnikov, M.B.; Aliev, O.I.; Sidekhmenova, A.V.; Shamanaev, A.Y.; Anishchenko, A.M.; Fomina, T.I.; Chernysheva, G.A.; Smol’yakova, V.I.; Arkhipov, A.M. Dihydroquercetin improves microvascularization and microcirculation in the brain cortex of SHR rats during the development of arterial hypertension. Bull. Exp. Biol. Med. 2017, 163, 57–60. [Google Scholar] [CrossRef] [PubMed]
  121. Kwak, C.J.; Kubo, E.; Fujii, K.; Nishimura, Y.; Kobuchi, S.; Ohkita, M.; Yoshimura, M.; Kiso, Y.; Matsumura, Y. Antihypertensive effect of French maritime pine bark extract (Flavangenol): Possible involvement of endothelial nitric oxide-dependent vasorelaxation. J. Hypertens. 2009, 27, 92–101. [Google Scholar] [CrossRef] [PubMed]
  122. Shah, Z.A.; Li, R.C.; Ahmad, A.S.; Kensler, T.W.; Yamamoto, M.; Biswal, S.; Doré, S. The flavanol (−)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J. Cereb. Blood Flow Metab. 2010, 30, 1951–1961. [Google Scholar] [CrossRef]
  123. Calabró, V.; Piotrkowski, B.; Fischerman, L.; Vazquez Prieto, M.A.; Galleano, M.; Fraga, C.G. Modifications in nitric oxide and superoxide anion metabolism induced by fructose overload in rat heart are prevented by (−)-epicatechin. Food Funct. 2016, 7, 1876–1883. [Google Scholar] [CrossRef] [PubMed]
  124. Yamazaki, K.G.; Taub, P.R.; Barraza-Hidalgo, M.; Rivas, M.M.; Zambon, A.C.; Ceballos, G.; Villarreal, F.J. Effects of (−)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. J. Am. Coll. Cardiol. 2010, 55, 2869–2876. [Google Scholar] [CrossRef]
  125. Guo, Y.; Wang, T.; Fu, F.F.; El-Kassaby, Y.A.; Wang, G. Temporospatial flavonoids metabolism variation in Ginkgo biloba leaves. Front. Genet. 2020, 11, 1503. [Google Scholar] [CrossRef]
  126. Shu, Z.; Yang, Y.; Yang, L.; Jiang, H.; Yu, X.; Wang, Y. Cardioprotective effects of dihydroquercetin against ischemia reperfusion injury by inhibiting oxidative stress and endoplasmic reticulum stress-induced apoptosis via the PI3K/Akt pathway. Food Funct. 2019, 10, 203–215. [Google Scholar] [CrossRef] [PubMed]
  127. Vasconcelos, P.C.D.P.; Seito, L.N.; Di Stasi, L.C.; Akiko Hiruma-Lima, C.; Pellizzon, C.H. Epicatechin used in the treatment of intestinal inflammatory disease: An analysis by experimental models. Evid. Based Complement. Alternat. Med. 2012, 2012, 508902. [Google Scholar] [CrossRef] [PubMed]
  128. Prince, P.D.; Fischerman, L.; Toblli, J.E.; Fraga, C.G.; Galleano, M. LPS-induced renal inflammation is prevented by (−)-epicatechin in rats. Redox Biol. 2017, 11, 342–349. [Google Scholar] [CrossRef] [PubMed]
  129. Kang, J.; Wang, Z.; Oteiza, P.I. (−)-Epicatechin mitigates high fat diet-induced neuroinflammation and altered behavior in mice. Food Funct. 2020, 11, 5065–5076. [Google Scholar] [CrossRef] [PubMed]
  130. Inoue, T.; Saito, S.; Tanaka, M.; Yamakage, H.; Kusakabe, T.; Shimatsu, A.; Ihara, M.; Satoh-Asahara, N. Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. USA 2019, 116, 10031–10038. [Google Scholar] [CrossRef] [PubMed]
  131. Zeng, Y.; Song, J.; Zhang, M.; Wang, H.; Zhang, Y.; Suo, H. Comparison of in vitro and in vivo antioxidant activities of six flavonoids with similar structures. Antioxidants 2020, 9, 732. [Google Scholar] [CrossRef] [PubMed]
  132. Sinegre, T.; Teissandier, D.; Milenkovic, D.; Morand, C.; Lebreton, A. Epicatechin influences primary hemostasis, coagulation and fibrinolysis. Food Funct., 2019, 10, 7291–7298. [Google Scholar] [CrossRef] [PubMed]
  133. Sinegre, T.; Milenkovic, D.; Bourgne, C.; Teissandier, D.; Nasri, Y.; Dannus, L.T.; Morand, C.; Lebreton, A. Impact of epicatechin on the procoagulant activities of microparticles. Nutrients, 2020, 12, 2935. [Google Scholar] [CrossRef] [PubMed]
  134. Plotnikov, M.B.; Aliev, O.I.; Sidekhmenova, A.V.; Shamanaev, A.Y.; Anishchenko, A.M.; Nosarev, A.V.; Pushkina, E.A. Modes of hypotensive action of dihydroquercetin in arterial hypertension. Bull. Exp. Biol. Med., 2017, 162, 353–356. [Google Scholar] [CrossRef]
  135. Kubatiev, A.A.; Yadigarova, Z.T.; Rud’ko, I.A.; Tyukavkina, N.A.; Bykov, V.A. Diquertin suppresses ADP- and thrombin-induced accumulation of cytoplasmic calcium in human thrombocytes. Pharm. Chem. J., 1999, 33, 629–630. [Google Scholar] [CrossRef]
  136. Ivanov, I.S.; Sidehmenova, A.V.; Smol’yakova, V.I.; Chernysheva, G.A.; Plotnikov, M.B. Inhibition of adenosine diphosphate-induced platelet aggregation by alpha-lipoic acid and dihydroquercetin in vitro. Indian J. Pharmacol., 2014, 46, 430–432. [Google Scholar] [PubMed]
  137. Chen, Y.; Deuster, P. Comparison of quercetin and dihydroquercetin: Antioxidant-independent actions on erythrocyte and platelet membrane. Chem. Biol. Interact. 2009, 182, 7–12. [Google Scholar] [CrossRef] [PubMed]
  138. Ruijters, E.J.; Weseler, A.R.; Kicken, C.; Haenen, G.R.; Bast, A. The flavanol (−)-epicatechin and its metabolites protect against oxidative stress in primary endothelial cells via a direct antioxidant effect. Eur. J. Pharmacol. 2013, 715, 147–153. [Google Scholar] [CrossRef] [PubMed]
  139. Kostyuk, V.A.; Potapovich, A.I.; Strigunova, E.N.; Kostyuk, T.V.; Afanas’ev, I.B. Experimental evidence that flavonoid metal complexes may act as mimics of superoxide dismutase. Arch. Biochem. Biophys. 2004, 428, 204–208. [Google Scholar] [CrossRef] [PubMed]
  140. Shubina, V.S.; Shatalin, Y.V. Antioxidant and iron-chelating properties of taxifolin and its condensation product with glyoxylic acid. J. Food Sci. Technol. 2017, 54, 1467–1475. [Google Scholar] [CrossRef]
  141. Gómez-Guzmán, M.; Jiménez, R.; Sánchez, M.; Romero, M.; O’Valle, F.; Lopez-Sepulveda, R.; Quintela, A.M.; Galindo, P.; Zarzuelo, M.J.; Bailón, E.; et al. Chronic (−)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats. Br. J. Nutr. 2011, 106, 1337–1348. [Google Scholar] [CrossRef] [PubMed]
  142. Prince, P.D.; Fraga, C.G.; Galleano, M. (−)-Epicatechin administration protects kidneys against modifications induced by short-term l-NAME treatment in rats. Food Funct. 2020, 11, 318–327. [Google Scholar] [CrossRef] [PubMed]
  143. Sakuma, S.; Kishiwaki, Y.; Matsumura, M.; Sawada, H.; Hashimoto, R.; Gotoh, K.; Umemoto, K.; Fujimoto, Y. Taxifolin Potently Diminishes Levels of Reactive Oxygen Species in Living Cells Possibly by Scavenging Peroxyl Radicals. Am. J. Pharmacol. Toxicol. 2018, 13, 1–6. [Google Scholar] [CrossRef]
  144. Gómez-Guzmán, M.; Jiménez, R.; Sánchez, M.; Zarzuelo, M.J.; Galindo, P.; Quintela, A.M.; López-Sepulveda, R.; Romero, M.; Tamargo, J.; Vargas, F.; et al. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic. Biol. Med. 2012, 52, 70–79. [Google Scholar] [CrossRef]
  145. Prince, P.D.; Lanzi, C.R.; Toblli, J.E.; Elesgaray, R.; Oteiza, P.I.; Fraga, C.G.; Galleano, M. Dietary (−)-epicatechin mitigates oxidative stress, NO metabolism alterations, and inflammation in renal cortex from fructose-fed rats. Free Radic. Biol. Med. 2015, 90, 35–46. [Google Scholar] [CrossRef]
  146. Morrison, M.; Van der Heijden, R.; Heeringa, P.; Kaijzel, E.; Verschuren, L.; Blomhoff, R.; Kooistra, T.; Kleemann, R. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NF-kB in vivo. Atherosclerosis 2014, 233, 149–156. [Google Scholar] [CrossRef] [PubMed]
  147. Prince, P.D.; Rodríguez Lanzi, C.; Fraga, C.G.; Galleano, M. Dietary (−)-epicatechin affects NF-κB activation and NADPH oxidases in the kidney cortex of high-fructose-fed rats. Food Funct. 2019, 10, 26–32. [Google Scholar] [CrossRef] [PubMed]
  148. Wang, Y.-H.; Wang, W.-Y.; Chang, C.-C.; Liou, K.-T.; Sung, Y.-J.; Liao, J.-F.; Chen, C.-F.; Chang, S.; Hou, Y.-C.; Chou, Y.-C.; et al. Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kB activation. J. Biomed. Sci. 2006, 13, 127–141. [Google Scholar] [CrossRef] [PubMed]
  149. Ding, T.; Wang, S.; Zhang, X.; Zai, W.; Fan, J.; Chen, W.; Bian, Q.; Luan, J.; Shen, Y.; Zhang, Y.; et al. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine 2018, 41, 45–53. [Google Scholar] [CrossRef]
  150. Ye, Y.; Wang, X.; Cai, Q.; Zhuang, J.; Tan, X.; He, W.; Zhao, M. Protective effect of taxifolin on H2O2-induced H9C2 cell pyroptosis. Zhong Nan Da Xue Xue Bao. Yi Xue Ban J. Cent. South Univ. Med. Sci. 2017, 42, 1367–1374. [Google Scholar]
Preprints 102785 g001
Figure 1. Number of articles published on nailfold capillaroscopy < Full articles published from 1980 to 2023 were retrieved from PubMed using the search word “nailfold capillaroscopy”. (*2023: Up to October) >.
Figure 1. Number of articles published on nailfold capillaroscopy < Full articles published from 1980 to 2023 were retrieved from PubMed using the search word “nailfold capillaroscopy”. (*2023: Up to October) >.
Preprints 102785 g001
Preprints 102785 g002
Figure 2. Surveyed results of recently published nailfold capillaroscopy papers (1999 to 2023).
Figure 2. Surveyed results of recently published nailfold capillaroscopy papers (1999 to 2023).
Preprints 102785 g002
Preprints 102785 g003
Figure 3. Representative images of nailfold capillaries. The straight and long loops were commonly correlated with being healthy (A, B). Twisted or bushy loops (C, D), and non-dense and small loops (E, F) were commonly correlated with being unhealthy. < From: Nakajima, T, et al.: Nailfold capillary patterns correlate with age, gender, lifestyle habits, and fingertip temperature. PLOS ONE, 17, e0269661 2022 [27] >.
Figure 3. Representative images of nailfold capillaries. The straight and long loops were commonly correlated with being healthy (A, B). Twisted or bushy loops (C, D), and non-dense and small loops (E, F) were commonly correlated with being unhealthy. < From: Nakajima, T, et al.: Nailfold capillary patterns correlate with age, gender, lifestyle habits, and fingertip temperature. PLOS ONE, 17, e0269661 2022 [27] >.
Preprints 102785 g003
Preprints 102785 g004
Figure 4. Structures of nailfold capillaries correlated with lifestyle habits. Upper: Representative dot plot showing length of the loop of nailfold capillaries negatively correlated with the frequency of drinking. Dashed line: least-squares line. Lower: Schematic representation of the correlation between the nailfold capillary structure and lifestyle habits. < Cited from: Nakajima, T, et al.: Nailfold capillary patterns correlate with age, gender, lifestyle habits, and fingertip temperature. PLOS ONE, 17, e0269661, 2022 [27] >.
Figure 4. Structures of nailfold capillaries correlated with lifestyle habits. Upper: Representative dot plot showing length of the loop of nailfold capillaries negatively correlated with the frequency of drinking. Dashed line: least-squares line. Lower: Schematic representation of the correlation between the nailfold capillary structure and lifestyle habits. < Cited from: Nakajima, T, et al.: Nailfold capillary patterns correlate with age, gender, lifestyle habits, and fingertip temperature. PLOS ONE, 17, e0269661, 2022 [27] >.
Preprints 102785 g004
Table 1. Normal capillaroscopic pattern in healthy subjects.
Table 1. Normal capillaroscopic pattern in healthy subjects.
Parameter Description
Skin transparency Allows a good visualization of the capillaries
Subpapillary venous plexus Visible in up to 30% of healthy individuals
General view Homogeneously sized, regularly arranged
Capillary orientation Straight, parallel fashion, usually perpendicular to the nailfold
Capillary density Number of capillaries over 1 mm nailfold, more than 7 capillaries/mm
Capillary morphology Inverted "U", hairpin shape, but also tortuous and/ or crossing capillaries (nonspecific variations)
Capillary length less than 300 mm
Capillary diameter less than 20 mm for each loop (afferent, apical, efferent)
Pericapillary edema Absent
Hemorrhages Absent (occasionally observed after microtrauma)
Giant capillary Absent
Neoangiogenesis Absent
Blood flow characteristics Dynamic, no stasis
Table 2. Summary of nailfold capillaroscopy (NFC) morphology in normal healthy subjects
Table 2. Summary of nailfold capillaroscopy (NFC) morphology in normal healthy subjects
Authors and Published Year NFC morphology
Ingegnoli, F., et al. 2013, Microvasc. Res., 90, 90–95. [16] Based on the cluster analysis three major “normal” morphologic capillaroscopic patterns were depicted: 1) the “normal” pattern mainly with 2 to 5 U-shaped loops/mm and ≤2 tortuous loops/mm; 2) the “perfect normal” pattern with ≥5 U-shaped loops/mm; and 3) the “unusual normal” with at least 1 meandering or bushy loop, or at least 1 microhemorrhage, or with N4 crossed loops/mm. Regarding the loop measurements, the majority of subjects had a median of 7 capillaries/mm with a median length of 198 μm.
Faggioli, P., et al. 2015,
Italian J. of Med., 9, 234-242. [17]		 Under physiological conditions the normal pattern is characterized by: 1) the orderly arrangement of the capillaries to comb; 2) density of 9-13 mm (maximum 3 per dermal papilla); 3) 6-9µm diameter afferent branch, efferent branch 8-21µm (>50 micron: megacapillaries); 4) length 200-500 µm.
Tavakol, M.E., et al. 2015, Biomed. Res. Int., 2015, 974530. [14] Nailfold capillary density appears to be similar in healthy adults and healthy children across Europe. European authors found the mean capillary density in healthy children to be in the range of 5–7.3 compared to 7.3–10.3 in healthy adults. Brazilian authors showed slightly higher capillary counts, ranging from 6–7.3 capillaries per millimeter in children to 9.11–10.1 capillaries per millimeter in adults.
Emrani, Z., et al. 2017, Microvasc. Res., 109, 7–18. [13] Density of finger capillaries in healthy control subjects were summarized by collecting 17 articles published from 1990 to 2016 as follows. The average capillary density was 8.45 ± 1.32/mm for individuals aged 40 or less and 8.71 ± 1.40 for individuals older than 40 years of age in healthy subjects*. Moreover, the average capillary densities in healthy males and females were found to be 8.83 ± 1.50 and 8.60 ± 1.26/mm, respectively.**
< *Ingegnoli, F., Herrick, A.L., 2013. Nailfold capillaroscopy in pediatrics. Arthritis Care Res. 65, 1393–1400. **Hoerth, C., Kundi, M., Katzeschlager, R., Hirschl, M., 2012. Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers. Vasa, 41, 19–26. >
Table 3. Result of various morphological characteristics.
Table 3. Result of various morphological characteristics.
Nailfold capillary Dilated Neoangio-genesis Meandering Tortuous Ramified Plexus Visibility Micro hemorrhage Receding Angulated
Male (72) 25 29 34 29 4 29 4 23 9
% 34.72 40.27 47.22 40.27 5.55 40.27 5.55 31.94 12.5
Female (78) 25 29 33 39 6 26 4 24 13
% 32.05 37.17 42.3 50 7.69 33.33 5.12 30.76 16.66
P 0.8624 0.8247 0.549 0.3026 0.8442 0.3797 0.9074 0.8768 0.6244
BMI*<24.9 (84) 30 38 42 36 5 38 4 24 15
% 35.71 45.23 50 42.85 5.95 45.23 4.76 28.571 17.85
BMI* >25 (66) 20 20 25 32 5 17 4 23 7
% 30.3 30.3 37.87 48.48 7.57 25.75 6.06 34.84 10.6
P 0.6007 0.0909 0.1879 0.6016 0.9474 0.0222** 0.7253 0.5187 0.3108
20-40 years (78) 22 31 34 23 3 32 5 17 11
% 28.2 39.74 43.58 29.48 3.84 41.02 6.41 21.79 14.1
41-60 years (72) 28 27 33 45 7 23 3 30 11
% 38.88 37.5 45.83 62.5 9.72 31.94 4.61 41.66 15.27
P 0.225 0.9092 0.911 0.0002** 0.2654 0.3254 0.8074 0.0229** 0.9699
* BMI = Body Mass Index, ** significant difference. < From Gorasiya, AR, et al.: Indian J. Dermatol., 13, 600-605, 2022 [26] >　.
Table 4. Number of fingertip capillary vessel was measured after 3 months ingestion of LPSp supplement or Control.
Table 4. Number of fingertip capillary vessel was measured after 3 months ingestion of LPSp supplement or Control.
Control (n=26) LPSp supplement (n=26)
Months (m) 0 m +3 m 0 m +3 m
Per field 4.92 ± 0.30 4.42 ± 0.25 4.65 ± 0.25 5.12 ± 0.271
Relative value 1.0 ± 0.0 1.057 ± 0.17 1.0 ± 0.0 1.201 ± 0.10
Nailfold capillaroscopy was measured in the area near lunula of the left ring finger. 1 Control +3 m vs. LPSp supplement +3 m, p < 0.05 by Mann–Whitney U test. From: Nakata, Y., et al.: Effects of 3 months Continuous intake of supplement containing Pantoea agglomerans LPS to maintain normal bloodstream in adults. < Nakata, Y., et al.: Food Sci. Nutr., 2017, 1-10. [28] >.
Table 5. Paralleled relationship of NFC (nailfold capillaroscopy) data and PAD (peripheral artery diseases)-relating condition.
Table 5. Paralleled relationship of NFC (nailfold capillaroscopy) data and PAD (peripheral artery diseases)-relating condition.
Authors and Published Year Title and Description
<Example 1 >
Lundwall, K., et al., 2015		 Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial
< Am. J. Nephrol., 42, 265-273, 2015 > [38] Endothelial function declined significantly over 3 months in patients with moderate CKD, and this decline could be ameliorated by VDRA (vitamin D receptor activator) treatment, possibly through increased capillary blood flow.
<Example 2 >
Maranhao, P.A., et al., 2016 		Dynamic Nailfold Videocapillaroscopy may be Used for Early Microvascular Dysfunction in Obesity
< Microvasc. Res., 106, 31-35, 2016 > [39] The authors could speculate that the derangement on microvascular hemodynamics occurs before the diagnosis of hypertension, diabetes and other metabolic syndromes. Therefore, NFC is the most appropriate technique to precociously assess microvascular dysfunction in obesity.
< Example 3 >
Tian, J., et al., 2020 		The Relationship Between Nailfold Microcirculation and Retinal Microcirculation in Healthy Subjects
< Front. Physiol., 11, article 880; Sec. Vascular Physiology, 2020 > [40] In healthy subjects, there was direct relationship between nailfold capillary and retinal microcirculation. Therefore, abnormalities seen in the NFC are associated with reduced retinal nerve fiber layer (RNFL) thickness and retinal vessel density (VD).
< Example 4 >
Wijnand, J.G.J., et al., 2022 		Naiflold Capillaroscopy in Patients with Peripheral Artery Disease of the Lower Limb (CAPAD Study)
< Eur. J. Endovascl Surg., 63, 900-901, 2022 > [41] NFC abnormalities can be used as markers for inflammation and endothelial dysfunction in PAD.
＜Example 5＞
Okabe, T., et al., 2023 		Relationship between Nailfold Capillaroscopy Parameters and the Severity of Diabetic Retinopathy
< Graefe's Archive Clin. & Exp. Ophthalmol., doi:10.1007/s00417- 023-06220-z., 2023 > [42] Alterations in NFC morphology, such as capillary shortening, may be closely correlated with the presence of DR (diabetic retinopathy) and PDR (proliferative DR).
Table 6. List of authorized claims in the USA with direct or indirect impact on microcirculation.
Table 6. List of authorized claims in the USA with direct or indirect impact on microcirculation.
Preprints 102785 i001
Table 7. List of nonauthorized claims in the EU with the word microcirculation.
Table 7. List of nonauthorized claims in the EU with the word microcirculation.
Preprints 102785 i002
Table 8. Summarized protective effects of (-)-epicatechin and (+)-taxifolin and/or (-)-taxifolin on cardiovascular diseases in animal models. [105].
Table 8. Summarized protective effects of (-)-epicatechin and (+)-taxifolin and/or (-)-taxifolin on cardiovascular diseases in animal models. [105].
Preprints 102785 i003
Table 9. . Summarized anti-oxidative and anti-inflammatory effects of (-)-epicatechin and (+)-taxifolin and/or (-)-taxifolin on endothelial function. [105].
Table 9. . Summarized anti-oxidative and anti-inflammatory effects of (-)-epicatechin and (+)-taxifolin and/or (-)-taxifolin on endothelial function. [105].
Preprints 102785 i004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated